The Evolution and Application of Cardiac Monitoring for Occult Atrial Fibrillation in Cryptogenic Stroke and TIA
详细信息    查看全文
Culebras A, Messé SR, Chaturvedi S, Kase CS, Gronseth G. Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014;82(8):716–24. This guideline provides the most up to date evidence based approach to patient management in the prevention of stroke in non-valvular atrial fibrillation. However, additional evidence has surfaced as referenced in this review that has not yet been compiled into an updated guideline.CrossRef PubMed PubMedCentral
2.••
Kernan WN, Ovbiagele B, Black H, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:2160–236. This guideline provides the most up to date evidence based approach to patient management in the secondary prevention of stroke. However, additional evidence has surfaced as referenced in this review that has not yet been compiled into an updated guideline.CrossRef PubMed
3.•
Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370(26):2467–77. This study is one of two important randomized controlled trials confirming a benefit of prolonged monitoring (30 days) over 24 hour Holter monitoring and will likely be the basis for future guideline recommendations.CrossRef PubMed
4.•
Sanna T, Diener H-C, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478–86. This study is one of two important randomized controlled trials confirming a benefit of prolonged monitoring (up to 3 yrs) over 24 hour Holter monitoring and will likely be the basis for future guideline recommendations.CrossRef PubMed
5.Committee ESOE, Committee EW. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25(5):457–507.CrossRef
6.Sposato LA, Cipriano LE, Saposnik G, Vargas ER, Riccio PM, Hachinski V. Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2015;14(4):377–87.CrossRef PubMed
7.Holter NJ. New method for heart studies. Science (New York, NY). 1961;134(3486):1214–20.CrossRef
8.Ritter MA, Kochhäuser S, Duning T, Reinke F, Pott C, Dechering DG, et al. Occult atrial fibrillation in cryptogenic stroke detection by 7-day electrocardiogram versus implantable cardiac monitors. Stroke. 2013;44(5):1449–52.CrossRef PubMed
9.Gunalp M, Atalar E, Coskun F, Yilmaz A, Aksoyek S, Aksu NM, et al. Holter monitoring for 24 hours in patients with thromboembolic stroke and sinus rhythm diagnosed in the emergency department. Adv Ther. 2006;23(6):854–60.CrossRef PubMed
10.Poli S, Diedler J, Härtig F, Götz N, Bauer A, Sachse T, et al. Insertable cardiac monitors after cryptogenic stroke—a risk factor based approach to enhance the detection rate for paroxysmal atrial fibrillation. Eur J Neurol. 2015.
11.Varounis C, Dagres N, Maounis T, Panagiotakos D, Cokkinos DV. Atrial premature complexes and heart rate have prognostic significance in 1-month atrial fibrillation recurrence after electrical cardioversion. Europace. 2007;9(8):633–7.CrossRef PubMed
12.Wallmann D, Tüller D, Wustmann K, Meier P, Isenegger J, Arnold M, et al. Frequent atrial premature beats predict paroxysmal atrial fibrillation in stroke patients an opportunity for a new diagnostic strategy. Stroke. 2007;38(8):2292–4.CrossRef PubMed
13.Binici Z, Intzilakis T, Nielsen OW, Køber L, Sajadieh A. Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation. 2010;121(17):1904–11.CrossRef PubMed
14.Gaillard N, Deltour S, Vilotijevic B, Hornych A, Crozier S, Leger A, et al. Detection of paroxysmal atrial fibrillation with transtelephonic EKG in TIA or stroke patients. Neurology. 2010;74(21):1666–70.CrossRef PubMed
15.Gladstone DJ, Dorian P, Spring M, Panzov V, Mamdani M, Healey JS, et al. Atrial premature beats predict atrial fibrillation in cryptogenic stroke results from the EMBRACE trial. Stroke. 2015;46(4):936–41.CrossRef PubMed
16.Rosenberg MA, Samuel M, Thosani A, Zimetbaum PJ. Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study. Pacing Clin Electrophysiol. 2013;36(3):328–33.CrossRef PubMed PubMedCentral
17.Brachmann J, Morillo CA, Sanna T, Di Lazzaro V, Diener HC, Bernstein RA, et al. Uncovering atrial fibrillation beyond short-term monitoring in cryptogenic stroke patients: three-year results from the cryptogenic stroke and underlying atrial fibrillation trial. Circ Arrhythm Electrophysiol. 2016;9(1), e003333. doi:10.​1161/​circep.​115.​003333 .CrossRef PubMed
18.Tayal A, Tian M, Kelly K, Jones S, Wright D, Singh D, et al. Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology. 2008;71(21):1696–701.CrossRef PubMed
19.Miller DJ, Khan MA, Schultz LR, Simpson JR, Katramados AM, Russman AN, et al. Outpatient cardiac telemetry detects a high rate of atrial fibrillation in cryptogenic stroke. J Neurol Sci. 2013;324(1):57–61.CrossRef PubMed
20.Sposato LA, Cipriano LE, Riccio PM, Hachinski V, Saposnik G. Very short paroxysms account for more than half of the cases of atrial fibrillation detected after stroke and TIA: a systematic review and meta-analysis. Int J Stroke. 2015;10(6):801–7. doi:10.​1111/​ijs.​12555 .CrossRef PubMed
21.Khan M, Miller DJ, Schultz LR. Indecision in the clinical practice of anticoagulation for brief atrial arrhythmias after cryptogenic stroke. J Stroke Cerebrovasc Dis. 2013;22(8):e500–3. doi:10.​1016/​j.​jstrokecerebrova​sdis.​2013.​05.​019 .CrossRef PubMed
22.Rothman SA, Laughlin JC, Seltzer J, Walia JS, Baman RI, Siouffi SY, et al. The diagnosis of cardiac arrhythmias: a prospective multi‐center randomized study comparing mobile cardiac outpatient telemetry versus standard loop event monitoring. J Cardiovasc Electrophysiol. 2007;18(3):241–7.CrossRef PubMed
23.Giada F, Bertaglia E, Reimers B, Noventa D, Raviele A. Current and emerging indications for implantable cardiac monitors. Pacing Clin Electrophysiol. 2012;35(9):1169–78.CrossRef PubMed
24.Hindricks G, Pokushalov E, Urban L, Taborsky M, Kuck K-H, Lebedev D, et al. Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation results of the XPECT trial. Circ Arrhythm Electrophysiol. 2010;3(2):141–7.CrossRef PubMed
25.Podd SJ, Sugihara C, Furniss SS, Sulke N. Are implantable cardiac monitors the ‘gold standard’ for atrial fibrillation detection? a prospective randomized trial comparing atrial fibrillation monitoring using implantable cardiac monitors and DDDRP permanent pacemakers in post atrial fibrillation ablation patients. Europace. 2015. doi:10.​1093/​europace/​euv367 .
26.Christensen L, Krieger D, Højberg S, Pedersen O, Karlsen F, Jacobsen M, et al. Paroxysmal atrial fibrillation occurs often in cryptogenic ischaemic stroke. Final results from the SURPRISE study. Eur J Neurol. 2014;21(6):884–9.CrossRef PubMed
27. http://​www.​mdbuyline.​com/​blog/​for-conveniences-sake-medtronics-move-for-in-office-icm-procedures ; Last accessed: January 2016.
28. https://​clinicaltrials.​gov/​ct2/​show/​NCT02395536?​term=​NCT02395536&​rank=​1 ; Last accessed: January 2016.
29.Kanters TA, Wolff C, Boyson D, Kouakam C, Dinh T, Hakkaart L, et al. Cost comparison of two implantable cardiac monitors in two different settings: reveal XT in a catheterization laboratory vs. Reveal LINQ in a procedure room. Europace. 2015;2015, euv217.CrossRef
30.Houmsse M, Ishola A, Daoud EG. Clinical utility of implantable loop recorders. Postgrad Med. 2014;126(2):30–7.CrossRef PubMed
31.Brignole M, Vardas P, Hoffman E, Huikuri H, Moya A, Ricci R, et al. Indications for the use of diagnostic implantable and external ECG loop recorders. Europace. 2009;11(5):671–87.CrossRef PubMed
32.Rosero SZ, Kutyifa V, Olshansky B, Zareba W. Ambulatory ECG monitoring in atrial fibrillation management. Prog Cardiovasc Dis. 2013;56(2):143–52.CrossRef PubMed
33.Afzal MR, Gunda S, Waheed S, Sehar N, Maybrook RJ, Dawn B, et al. Role of outpatient cardiac rhythm monitoring in cryptogenic stroke: a systematic review and meta‐analysis. Pacing Clin Electrophysiol. 2015;38(10):1236–45.CrossRef PubMed
34.Bernstein RA, Di Lazzaro V, Rymer MM, Passman RS, Brachmann J, Morillo CA, et al. Infarct topography and detection of atrial fibrillation in cryptogenic stroke: results from CRYSTAL AF. Cerebrovasc Dis. 2015;40(1–2):91–6.CrossRef PubMed
35.Thijs VN, Brachmann J, Morillo CA, Passman RS, Sanna T, Bernstein RA, et al. Predictors for atrial fibrillation detection after cryptogenic stroke results from CRYSTAL AF. Neurology. 2015. doi:10.​1212/​WNL.​0000000000002282​ .
36.Kamel H, Lees KR, Lyden PD, Teal PA, Shuaib A, Ali M, et al. Delayed detection of atrial fibrillation after ischemic stroke. J Stroke Cerebrovasc Dis. 2009;18(6):453–7.CrossRef PubMed
37.Suissa L, Bertora D, Lachaud S, Mahagne MH. Score for the targeting of atrial fibrillation (STAF) a New approach to the detection of atrial fibrillation in the secondary prevention of ischemic stroke. Stroke. 2009;40(8):2866–8.CrossRef PubMed
38.Alhadramy O, Jeerakathil TJ, Majumdar SR, Najjar E, Choy J, Saqqur M. Prevalence and predictors of paroxysmal atrial fibrillation on holter monitor in patients with stroke or transient ischemic attack. Stroke. 2010;41(11):2596–600.CrossRef PubMed
39.Skaarup KG, Christensen H, Høst N, Mahmoud MM, Ovesen C, Olsen FJ, et al. Diagnosing paroxysmal atrial fibrillation in patients with ischemic strokes and transient ischemic attacks using echocardiographic measurements of left atrium function. Am J Cardiol. 2016;117(1):91–9.CrossRef PubMed
40.Miller JD, Aronis KN, Chrispin J, Patil KD, Marine JE, Martin SS, et al. Obesity, exercise, obstructive sleep apnea, and modifiable atherosclerotic cardiovascular disease risk factors in atrial fibrillation. J Am Coll Cardiol. 2015;66(25):2899–906. doi:10.​1016/​j.​jacc.​2015.​10.​047 .CrossRef PubMed
41.Bhatt A, Majid A, Razak A, Kassab M, Hussain S, Safdar A. Predictors of occult paroxysmal atrial fibrillation in cryptogenic strokes detected by long-term noninvasive cardiac monitoring. Stroke research and treatment. 2011;2011.
42.Cotter PE, Martin PJ, Ring L, Warburton EA, Belham M, Pugh PJ. Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke. Neurology. 2013;80(17):1546–50. doi:10.​1212/​WNL.​0b013e31828f1828​ .CrossRef PubMed PubMedCentral
43.Horstmann S, Rizos T, Guntner J, Hug A, Jenetzky E, Krumsdorf U, et al. Does the STAF score help detect paroxysmal atrial fibrillation in acute stroke patients? Eur J Neurol. 2013;20(1):147–52. doi:10.​1111/​j.​1468-1331.​2012.​03816.​x .CrossRef PubMed
44.Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139–51.CrossRef PubMed
45.Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883–91.CrossRef PubMed
46.Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981–92.CrossRef PubMed
47.Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):2093–104.CrossRef PubMed
48.Pollack Jr CV, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, et al. Idarucizumab for dabigatran reversal. N Engl J Med. 2015;373(6):511–20.CrossRef PubMed
49.Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, et al. Andexanet alfa for the reversal of factor Xa inhibitor activity. N Engl J Med. 2015;373(25):2413–24.CrossRef PubMed
50.Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, et al. Apixaban in patients with atrial fibrillation. N Engl J Med. 2011;364(9):806–17. doi:10.​1056/​NEJMoa1007432 .CrossRef PubMed
51.Reddy VY, Mobius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol. 2013;61(25):2551–6. doi:10.​1016/​j.​jacc.​2013.​03.​035 .CrossRef PubMed
52.Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the watchman left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the continued access registry. Circulation. 2011;123(4):417–24. doi:10.​1161/​circulationaha.​110.​976449 .CrossRef PubMed
53.Holmes Jr DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, et al. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1–12. doi:10.​1016/​j.​jacc.​2014.​04.​029 .CrossRef PubMed
54.Srivastava MC, See VY, Dawood MY, Price MJ. A review of the LARIAT device: insights from the cumulative clinical experience. SpringerPlus. 2015;4:522. doi:10.​1186/​s40064-015-1289-8 .CrossRef PubMed PubMedCentral
  • 作者单位:Daniel J. Miller MD (1)
    Kavit Shah MD (1)
    Sumul Modi MD (1)
    Abhimanyu Mahajan MD, MHS (1)
    Salman Zahoor MD (1)
    Muhammad Affan MD (1)

    1. Department of Neurology, Henry Ford Hospital, 2799 West Grand Blvd, Detroit, MI, 48202, USA
  • 刊物主题:Neurology; Intensive / Critical Care Medicine; Internal Medicine; Ophthalmology; General Practice / Family Medicine; Diabetes;
  • 出版者:Springer US
  • ISSN:1534-3138
  • 文摘

    © 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

    地址:北京市海淀区学院路29号 邮编:100083

    电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700